Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Long-Term Debt RepaymentsShares IssuedShares OutstandingShares Outstanding
Ratios

Tenax Therapeutics (TENX) Long-Term Debt Repayments (2022 - 2024)

Tenax Therapeutics' Long-Term Debt Repayments history spans 6 years, with the latest figure at $100160.0 for Q4 2015.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $100160.0 in Q4 2015 year-over-year; TTM through Sep 2016 was $100160.0, a 49.32% decrease, with the full-year FY2024 number at $501000.0, down 19.71% from a year prior.
  • Long-Term Debt Repayments hit $100160.0 in Q4 2015 for Tenax Therapeutics, up from $48209.0 in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for TENX hit a ceiling of $8.0 million in Q1 2012 and a floor of -$245010.0 in Q2 2015.
  • Historically, Long-Term Debt Repayments has averaged $502173.4 across 5 years, with a median of $34372.0 in 2013.
  • Biggest five-year swings in Long-Term Debt Repayments: soared 6163.24% in 2012 and later plummeted 100.7% in 2013.
  • Tracing TENX's Long-Term Debt Repayments over 5 years: stood at $8630.0 in 2011, then skyrocketed by 62.54% to $14027.0 in 2012, then skyrocketed by 65.16% to $23167.0 in 2013, then surged by 1400.24% to $347561.0 in 2014, then tumbled by 71.18% to $100160.0 in 2015.
  • Business Quant data shows Long-Term Debt Repayments for TENX at $100160.0 in Q4 2015, $48209.0 in Q3 2015, and -$245010.0 in Q2 2015.